With COVID-19, the world’s life science researchers and biopharma companies face an unprecedented challenge: They are mounting collaborative, industry-wide projects to discover and produce safe and effective therapies and vaccines as rapidly as possible.
In times like these, scientific researchers, drug developers and clinical study managers want experts who have the full breadth of knowledge and capabilities to support them so they can focus on their important work.
Avantor® is proud to collaborate with the companies on the forefront of COVID-19 research. They trust us to provide the solutions and services needed to fast-track virus detection, treatment development, clinical trials and production of existing and novel therapies to combat this pandemic.
From discovery to delivery, we provide mission-critical products and services to help scientists achieve research results faster and help manufacturers optimize their processes.
Our solutions are often specified in customers’ processes and products – and we are committed to delivering the resources and support needed to help drive breakthroughs across all viral detection and treatment development workflows.
Our mission of setting science in motion to create a better world is more important now than ever before.
Solutions to enable your work in coronavirus vaccines and COVID-19 therapies
Virus detection
Our total lab setup solution for virus sampling and detection includes products such as RT-qPCR solutions, sample collection kits and COVID-19 shippers, as well as lab management and scientific services to streamline sample testing and analysis.
Therapy development
Avantor enables fast-tracking for COVID-19 therapy breakthroughs by leveraging our extensive portfolio of laboratory products and expertise in lab and inventory management process improvement.
Clinical trials
We facilitate the acceleration of clinical trials for existing and novel therapies with proven biorepository and sampling archiving services, as well as custom kits and scientific equipment.
Vaccine and therapy production
As new therapies move from pilot to commercial manufacturing, Avantor is ready with trusted cGMP materials, innovative single-use technologies and the global regulatory expertise our customers need.